Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
RenovoRx (RNXT) Stock Price & Analysis
50 Followers
RNXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $3.29
Previous Close$1.22
Volume5.26K
Average Volume (3M)50.02K
Market Cap
$20.58M
Enterprise Value$17.38M
Total Cash (Recent Filing)$3.20M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.2
Beta1.68
Next Earnings
May 13, 2024EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding16,865,975
10 Day Avg. Volume115,067
30 Day Avg. Volume50,015
Standard Deviation0.54
R-Squared0.01
Alpha0.00906
Financial Highlights & Ratios
Price to Book (P/B)3175.58
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.55
Forecast
1Y Price Target
$3.75Price Target Upside207.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
RenovoRx News
PremiumCompany Announcements
RenovoRx Secures $11.1M Through Equity and Warrants Offering
PremiumCompany Announcements
RenovoRx Struggles to Avoid Nasdaq Delisting Amid Leadership Changes
Ownership Overview
2.71% Insiders
1.07% Mutual Funds
0.54% Other Institutional Investors
95.69% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RNXT FAQ
What was RenovoRx’s price range in the past 12 months?
RenovoRx lowest stock price was $0.53 and its highest was $3.29 in the past 12 months.
What is RenovoRx’s market cap?
Currently, no data Available
When is RenovoRx’s upcoming earnings report date?
RenovoRx’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were RenovoRx’s earnings last quarter?
RenovoRx released its earnings results on Mar 27, 2024. The company reported -$0.305 earnings per share for the quarter, the consensus estimate of -$0.305 by $0.
Is RenovoRx overvalued?
According to Wall Street analysts RenovoRx’s price is currently Undervalued.
Does RenovoRx pay dividends?
RenovoRx does not currently pay dividends.
What is RenovoRx’s EPS estimate?
RenovoRx’s EPS estimate is -$0.13.
How many shares outstanding does RenovoRx have?
RenovoRx has 16,865,974 shares outstanding.
What happened to RenovoRx’s price movement after its last earnings report?
RenovoRx reported an EPS of -$0.305 in its last earnings report, expectations of -$0.305. Following the earnings report the stock price went up 6.154%.
Which hedge fund is a major shareholder of RenovoRx?
Currently, no hedge funds are holding shares in RNXT
---
RenovoRx Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.75 (207.38% Upside)
$3.75 (207.38% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 18.7%
Last 30 Days ▼ 18.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.24%
12-Months-Change
Fundamentals
Return on Equity
-646.98%
Trailing 12-Months
Asset Growth
-79.82%
Trailing 12-Months
Company Description
RenovoRx
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
---
RNXT Stock 12 Months Forecast
Average Price Target
$3.75
▲(207.38% Upside)
Technical Analysis
Best Analysts Covering RNXT
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-40.69%
upgraded a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -40.69% per trade.
---